Section Arrow
VTVT.NASDAQ
- vTv Therapeutics
Quotes are at least 15-min delayed:2025/05/14 03:53 EDT
Last
 20.8
-0.66 (-3.08%)
Day High 
21.52 
Prev. Close
21.46 
1-M High
23.2 
Volume 
24.72K 
Bid
18.5
Ask
27.22
Day Low
20.1238 
Open
21.51 
1-M Low
18.15 
Market Cap 
56.06M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 20.98 
20-SMA 20.71 
50-SMA 18.54 
52-W High 29.01 
52-W Low 12.1201 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.20/-4.06
Enterprise Value
56.06M
Balance Sheet
Book Value Per Share
4.67
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.02M
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PLRZPolyrizon Ltd0.0285-0.3215-91.86%-- 
CNSPCNS Pharmaceuticals Inc.1.36+0.15+12.40%0PE
NCNANuCana plc0.0329-0.0071-17.75%-- 
HCWBHCW Biologics Inc10.05+4.84+92.90%-- 
XLOXilio Therapeutics1.15+0.419+57.32%-- 
Quotes are at least 15-min delayed:2025/05/14 03:53 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.